Additionally, XN regulates the anti-angiogenic effects of NF-κB by suppressing the level of MMP-9, VEGF, and ICAM-1 stimulated by TNF in chronic myelogenous leukemia [115]. The gene discussed is NFKB1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.